Optima Capital’s Medtronic MDT Stock Holding History

Optima Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-184	Closed	-$17.8K	–	834
2025 Q4	$17.8K	Buy	+184	New	+$17.9K	0.01%	446

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optima Capital's MDT Position: Q1 2026 in Review

Optima Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 184 shares — an estimated $17.8K sold.

Optima Capital first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $17.8K in Q4 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Optima Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Optima Capital sold 184 Medtronic shares in Q1 2026, an estimated $17.8K.
Optima Capital first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
Optima Capital's Medtronic position peaked at $17.8K in Q4 2025.
2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.